Back to Search
Start Over
Atreca Announces Publication in PNAS: 'Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101'
- Source :
- Legal Monitor Worldwide. May 5, 2022
- Publication Year :
- 2022
-
Abstract
- (GlobeNewswire) - Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.702549409